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Protoporphyrinogen IXoxidase, amonotopicmembranepro-
tein, which catalyzes the oxidation of protoporphyrinogen IX to
protoporphyrin IX in the heme/chlorophyll biosynthetic path-
way, is distributed widely throughout nature. Here we present
the structure of protoporphyrinogen IX oxidase fromMyxococ-
cus xanthus, an enzyme with similar catalytic properties to
human protoporphyrinogen IX oxidase that also binds the com-
mon plant herbicide, acifluorfen. In the native structure, the
planar porphyrinogen substrate ismimickedby aTween20mol-
ecule, tracing three sides of the macrocycle. In contrast, aciflu-
orfen does notmimic the planarity of the substrate but is accom-
modated by the shape of the binding pocket and held in place by
electrostatic and aromatic interactions. A hydrophobic patch
surrounded by positively charged residues suggests the position
of the membrane anchor, differing from the one proposed for
the tobacco mitochondrial protoporphyrinogen oxidase. Inter-
estingly, there is a discrepancy between the dimerization state of
the protein in solution and in the crystal. Conserved structural
features are discussed in relation to a number of South African
variegate porphyria-causing mutations in the human enzyme.
Protoporphyrinogen oxidase (PPOX)5 (EC 1.3.3.4), the
penultimate enzyme in the heme biosynthetic pathway, is the
last common enzyme in heme and chlorophyll biosynthesis. It
catalyzes the six-electron oxidation of protoporphyrinogen IX
to protoporphyrin IX (1, 2). In humans, defects in the PPOX
gene result in the dominantly inherited disorder variegate por-
phyria (VP) (3, 4), characterized by cutaneous photosensitivity
and the propensity to develop acute neurovisceral crisis (5).
This disease is particularly prevalent in South Africa because of
a founder gene effect (an R59W mutation) (6, 7). In plants,
PPOX is a target of light-dependent peroxidizing herbicides,
which act as competitive inhibitors (8) resulting in desiccation
and photobleaching of green plant tissue. Of the herbicides
known to inhibit PPOX, the diphenylethers, of which acifluor-
fen (AF) is the most well studied, are of great interest. Such
inhibition has also been documented in mammals and bacteria
(9, 10). Inhibition of the enzyme leads to the accumulation and
export of protoporphyrinogen to the cytoplasm, where it
undergoes non-enzymatic oxidation to porphyrin. In the pres-
ence of light, accumulation of protoporphyrin can lead to reac-
tive oxygen species that may induce cellular damage, primarily
via peroxidation of membrane lipids, and ultimately cell death.
A similar photodestructive mechanism, because of accumulat-
ing porphyrin intermediates in the skin of patients with VP, is
probably responsible for the photocutaneous manifestations in
this condition (11).
In eukaryotes, PPOX is functionally conserved despite a low
sequence identity. It is an intrinsic protein of the inner mito-
chondrial membrane and requires molecular oxygen and a fla-
vin cofactor (in most cases, flavin adenine dinucleotide (FAD))
for this conversion. However, it is possible that diverse catalytic
mechanisms may exist, especially in prokaryotes that can sur-
vive under both aerobic and anaerobic conditions (12, 13).
Three molecules of oxygen, the ultimate fate of which is hydro-
gen peroxide rather than water, serve as the final electron
acceptors in the aerobic reaction in both eukaryotic and most
prokaryotic PPOXs (14, 15). However, in the case ofEscherichia
coli the respiratory chain of the cell serves as the electron accep-
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tor, and in the anaerobeDesulfovibrio gigas the electron accep-
tor is unclear (13). The reaction proceeds via three two-electron
oxidations rather than a single six-electron oxidation. A mech-
anism for the removal of four hydrogens in the meso positions
of the porphyrin ring has been suggested inwhich three desatu-
ration steps occurwith the involvement of one particular face of
the porphyrin ring and one prototropic rearrangement step
using the other face of the ring (16).
In bacteria, PPOX enzymes are less well characterized and
exhibit relatively diverse behavior (17). Of the bacterial
enzymes studied, PPOX fromMyxococcus xanthus (mxPPOX)
ismost similar to the eukaryotic enzymes, being dimeric, mem-
brane-bound, and inhibited byAF (15). This is in contrast to the
PPOX fromBacillus subtilis, which ismonomeric, cytoplasmic,
has broader substrate specificity, and is not inhibited by AF
(18). An interesting feature of PPOX from M. xanthus is its
ability to convey herbicidal resistance to oxyfluorfen-treated
transgenic rice plants by overexpression of the engineered
PPOX gene to counteract the photodynamic stress in these
plants (19). Prokaryotic diversity with respect to the electron
acceptor/donor used also appears to exist (see above). PPOX
from the thermophile Aquifex aeolicus is most similar to
M. xanthus differing only in its monomeric state (20).
Recently, the crystal structure of mitochondrial tobacco
PPOX (mtPPOX) with a phenylpyrazol inhibitor has been
solved to a 2.9-Å resolution (21). The structure revealed it to be
a loosely associated dimer of a tri-lobed protein. The three lobes
were designated: a FAD-binding domain of the p-hydroxyben-
zoate hydroxylase type fold; a substrate-binding domain that
enclosed a narrow active site cavity beneath the FAD; and an
-helicalmembrane-binding domain (21).Here, we present the
first prokaryotic PPOX structure from M. xanthus. Despite a
low sequence identity with mtPPOX, the fold for both proteins
is largely conserved. However, the different charge distribution
of mxPPOX suggests an alternative membrane binding orien-
tation, and this, combined with the crystal packing, suggests
other differences in its dimerization interface. We also present
the crystal structure of mxPPOX bound to AF, allowing visual-
ization of this important complex for the first time. Further-
more, to elucidate the determinants of the active site important
for AF binding, we have compared our structure with a model
of the AF-resistant PPOX from B. subtilis.
EXPERIMENTAL PROCEDURES
Expression and Purification of M. xanthus PPOX—The
expression vector (pMx-PPO) containing M. xanthus cDNA
(22) was kindly donated by Prof. H. Dailey, University of Geor-
gia, Athens, GA. The vector was transfected into and main-
tained in E. coli JM109 cells. For expression of recombinant
mxPPOX, 3  1 ml of PPOX JM109 cell glycerol stocks were
inoculated into 3 1 liter of LBmedium and grown at 37 °C for
22 h with shaking. Cells were harvested by centrifugation
(4000  g, 30 min, 4 °C) and resuspended in 90 ml of 20 mM
Tris-HCl, 100 mM NaCl, 1% Tween 20, pH 8.0 (buffer A) prior
to sonication (four times for 30 s). The lysate was centrifuged
(105000  g) for 40 min and the supernatant loaded onto a
Talon resin (Clontech, Palo Alto, CA) column pre-equilibrated
with buffer A. After loading, the column was washed with
buffer A; buffer B (20 mM Tris-HCl, 100 mMNaCl, 0.5% Tween
20, 10% glycerol, pH 6.3); buffer C, (50 mM NaH2PO4, 100 mM
NaCl, 0.5% Tween 20, 10% glycerol, pH 6.3), and buffer C at pH
7.0 containing 25 mM imidazole. Elution was in buffer C (pH
7.0) containing 100 mM imidazole. Phenylmethylsulfonyl fluo-
ride (1 g/ml) was added throughout the purification proce-
dure, which was performed at room temperature. After purifi-
cation, 1.5 eq of FAD was added to the eluate. Purity of the
eluted PPOX was assessed by SDS-PAGE (7.5–17.5%) and pro-
tein concentrations determined by the Bio-Rad protein assay in
an aliquot excluding FAD. The protein was concentrated in a
30-kDa cut off Amicon concentrator, in a series of brief spins at
5000  g, until an estimated concentration of 12 mg/ml was
achieved and stored at 4 °C in the dark.
Crystallization, X-ray Data Collection, and Structure
Solution—For native mxPPOX, initial crystals in tetragonal
form were grown by the hanging drop vapor diffusion method
at 16 °C in the dark. 2 l of PPOX (3.7 mg/ml in 50 mM
Na2HPO4, 0.1 M NaCl, 10% glycerol, 0.5% Tween 20, pH 7, 0.15
mM FAD) was mixed with 2 l of well solution (100 mM Tris-
HCl, pH 8.5, 1.5 M (NH4)2SO4, 12% glycerol). A data set to 2.9 Å
was collected at 100 K on station PX 9.6 of the Synchrotron
Radiation Source, Daresbury, UK, using the well solution plus
25% glycerol as a cryoprotectant. The data were processed and
scaled to 2.9 Å using the HKL2000 software package (HKL
Research, Charlottesville, VA) (23). Later, crystals were grown
with increased glycerol and the addition of PEG4000 to thewell
solution (100mMTris-HCl, pH 7.5, 1.5 M (NH4)2SO4, 20% glyc-
erol, 1% PEG 4000) to decrease their solvent content. Addition-
ally, 1% PEG4000was added to thewell solution on 3 days prior
to data collection. The crystal diffracted to 2.7 Å at 100 K on
station PX 14.2 of the Synchrotron Radiation Source, Dares-
bury, UK. No additional cryoprotectant was used, but the cold
streamwas blocked for 5 s to anneal the crystal and remove the
ice rings. The data were processed with MOSFLM (24) and
scaledwith SCALA inCCP4 (25) to 2.7 Å (see Table 1). Both 2.9
and 2.7 Å data sets were collected using a Quantum 4 charge
coupled device detector (Area Detector Systems, Poway, CA).
The 2.9-Å data set was used for the initial structure solution.
As the data were only 86% complete, the space group was not
clear from systematic absences. Initial phases were determined
by molecular replacement with PHASER (26) in P4 (4 mole-
cules/asymmetric unit) using a truncated version of the mtP-
POX structure (ProteinData Bank code 1SEZ) (21). After initial
model building using O (27) and refinement with crystallogra-
phy NMR software using NCS restraints (28), a molecular
replacement solutionwas found for the newmodel usingMOL-
REP (29) in P4212 space group (2 molecules/asymmetric unit),
and refinement with NCS restraints was performed. Rigid body
refinement of this model with the 2.7-Å data in REFMAC gave
a free R-factor (R-free) of 34%. Further refinement using REF-
MAC (30) and model building using COOT (31) yielded a
model with a R-cryst of 25% and a R-free (3% of the reflections)
of 29% (see Table 1). During the refinement, FAD, water,
Tween 20, and glycerol molecules were added using COOT.
The final model contained 2 FAD molecules, 6 glycerol mole-
cules, three Tween 20molecules, and 146watermolecules. The
quality of the structure was validated with the programWHAT
Structure of Protoporphyrinogen Oxidase
38626 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 50•DECEMBER 15, 2006
 at UNIVERSITY O
F CAPE TO
W









IF (32), and the - conformational angle values were within
the normal range.
AcifluorfenmxPPOXComplex—AFwas fromChem Services
(West Chester, PA). mxPPOX at7mg/ml was incubated with
100 M AF (in 50 mM sodium phosphate, 0.1 M NaCl, 0.1 M
imidazole, pH 7, 2.5%Me2SO) on ice in the dark for 5 h. Onel
of complex was mixed with 1 l of well solution (100 mM Tris-
HCl, pH 7.5, 1.5 M (NH4)2SO4, 20% glycerol, 1% PEG 4000) and
suspended above the well as a hanging drop. Additionally, 1%
PEG 4000 was added to the well solution 3 days prior to data
collection. Data were collected at 100 K on station PX 14.1 of
the Synchrotron Radiation Source, Daresbury, UK. No addi-
tional cryoprotectant was used, but the cold-stream was
blocked for 5 s to anneal the crystal, although a small ice ring
was still present and reduced the completeness of the data
around3.5-Å resolution. The data were processed and scaled
in P4212 with HKL2000 to 2.3 Å (Table 1) (23). The native
mxPPOX was refined with the new data with REFMAC (30)
through CCP4i and the AF built into incomplete but clear dif-
ference density with the aid of COOT graphics program (31).
The final model contained 2 FAD, 5 glycerol, 2 AF, 1 Tween 20,
and 288watermolecules. The final structure hadR-cryst of 23%
and R-free (2% of the reflections) of 28% (see Table 1). The
stereochemistry of the structure was checked with WHAT IF
(32), and the - conformational angle values were within the
normal range. All figures were produced in Pymol (33) except
Fig. 1, A–D, which were prepared using Molscript (34) and
rendered in Povray, and Fig. 1E, which was prepared with
MDL ISIS/Draw 2.5.
RESULTS ANDDISCUSSION
Overall Structures—mxPPOX was crystallized in the space
group P4212 with two monomers (A and B) in the asymmetric
unit. Most of the model is well ordered for both the native
structure and the AF complex, with the exception of few resi-
dues at each termini, the loop from residues 208 to 214, which
are not visible in the map and a disordered region between
residues 88 and 93. Also, a few side chains in both structures
(mostly located on the surface of the molecules) are truncated
because of insufficient density. No ligand-dependent confor-
mational change in the mxPPOXAF structure was observed
(r.m.s.d. of 0.3 Å for 449 C atoms as calculated by the Dali
server (36)). Viewed from its flattest surface, mxPPOX
branches into three lobes, one mainly helical, one predomi-
nantly-sheet, and onemixed (Fig. 1A). In the case ofmtPPOX,
Koch et al. (21) designated these lobes as the membrane-, sub-
strate-, and FAD-binding domains, respectively. However,
these are probably referred to as pseudo-domains as they do not
fold independently.
Active Site Structure and Conservation—The mxPPOX
active site is a hydrophobic cavity seated at the interface of the
three pseudo-domains. An almost continuous chain of differ-
ence density was observed in the active site of the native struc-
ture that could not be accounted for by water or glycerol mol-
ecules. This density was finally modeled as a Tween 20
molecule, the long hydrophobic chain of which matches the
length of the density. Interestingly, the density had similar
shape and dimensions to the substrate (Fig. 1E), and the mod-
eled substrate (after energy minimization) matched the posi-
tion and orientation of the Tween (Fig. 2A).
The width of the active site is limited by Arg-95 and Gly-447
and is larger than the tetrapyrrole macrocycle. The modeled
macrocycle is sandwiched between the isoalloxazine ring of the
FAD, which acts as a ceiling, and the carbonyl oxygen of Gly-
167, which protrudes from the floor of the active site (Fig. 2A).
Although the sequence identity between PPOX enzymes is very
low, there are some well conserved residues in the active site
that can be rationalized in terms of themodeled substrate. Arg-
95, the equivalent of Arg-98 in the mtPPOX, is well conserved
across species and has been proposed to interact ionically with
ring C of the substrate (Fig. 1E) (21). The conservation of this
bulky residue on one side of the pocket has presumably con-
strained the size of the residue on the other side as it is always a
relatively small uncharged residue in the majority of species
(Ala, Gly, Thr, or Ser in all cases). Gly-167 is also conserved, and
its carbonyl oxygen, which protrudes from the floor of the cav-
ity to the center of the active site, probably serves to center the
tetrapyrrole macrocycle. Phe-329 that is conserved in many
species such as tobacco, human, and mouse is optimally placed
to limit the height of the ceiling of the cavity on the opposite
side of the macrocycle to the FAD. Other residues in the active
site are not conserved but show similarity in type or size among
many species. For example, Phe-392 inmtPPOX,which stacked
with the modeled porphyrin ring A, is not conserved is
mxPPOX. It is replaced by an equally bulky residue, Met-365,
that is also seen in human and mouse PPOXs.
Another non-conserved residue of more interest is Asn-63,
positioned on the opposite side of the isoalloxazine ring of FAD
to the substrate binding site (Fig. 2C). This residue is equivalent
to Arg-59 in human PPOX, and Arg-59-Trp mutation is by far
the most prevalent VP mutation identified to date (see “Varie-
gate Porphyria Mutations”). Human PPOX Arg-59 has also
been shown to be essential for enzymatic activity and structural




Space group P4212 P4212
Cell dimensions (a b, c) 148.6, 131.9 148.9, 132.7
Resolution range, Å 74.3–2.7 49.4–2.3
No. of reflections measured 309,546 139,157
No. of unique reflections 41,382 55,419
I/(I) (outer shell)a 14.7 (2.6) 8.7 (1.0)
Completeness (outer shell)a, % 100 (99.8) 75.2 (46.7)
Rsymm (outer shell)a, % 14.5 (57.1) 6.9 (53.1)
R-cryst, % 24.7 23.4
R-freeb, % 28.7 28.3
Average temperature factor, Å2
Protein (mol A/mol B) 31.1/30.6 34.3/33.8
FAD (A/B) 21.1/20.9 28.7/27.2
Acifluorfen (A/B) NAc 50.5/53.9
Tween (average over 3 molecules
(native)/1 molecule (complex))
63.6 65.5
Solvent (no. of water molecules) 17.8 (146) 28.0 (288)
r.m.s.d. from ideal values
Bond lengths, Å 0.006 0.010
Bond angles, ° 1.1 1.5
aOuter shell, 2.85–2.7Å and 2.38–2.3Å for the native data and acifluorfen complex,
respectively.
bR-free calculation used 2.1% and 3.1% of the reflections for the native data and
acifluorfen complex, respectively.
cNot applicable.
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structure that human PPOXArg-59 forms a salt bridge with an
aspartate (Asp-349) opposite, and that this helps maintain the
integrity of the active site. Although mxPPOX has different
residues at these positions, the resolution of our structures
allows us to visualize a hydrogen-bonding network surround-
ing Asn-63 mediated by several water molecules. Asn-63 forms
a hydrogen bond with nearby Arg-354, plus water mediated
interactions with nearby Ser-363, Glu-59, and the N-5 and O-4
atoms of the FAD cofactor. This
analysis agrees with the hypothesis
that this residue may be important
for active site integrity and stability,
holding together the FAD and the
substrate-binding pseudo-domains.
It also suggests that this residuemay
impact on the catalytic activity, as it
makes awater-mediated interaction
with the active N-5 atom of the
FAD.
There has been little work in elu-
cidating the precise mechanism of
PPOX oxidation. Akhtar (16) pro-
posed three desaturation reactions,
removing a hydride from one face of
the macrocycle followed by a proto-
topic rearrangement with a proton
removed from the other face of the
macrocycle. Further to this, Koch
et al. (21) suggested that all the elec-
trons are lost from a single point in
the macrocycle, based on the lack of
space for the substrate to rotate in the
active site and their modeled orienta-
tionof the ring in themtPPOXcrystal
structure. Although our structure
verifies that the substrate is unable to
rotate in the active site, we cannot
confirm the substrate orientation
proposed by Koch et al. (21). Both
structures show the porphyrin ring
has to lie horizontal to the active site
with the propionyl groups pointing
toward the cavity, but it is less clear
fromour structure, which half of the
ring should be closer to the FAD.
Although, the oxidation of half was
preferred by Akhtar (16), and this
half ismodeled closest to the FAD in
the model by Koch et al. (21), our
structure does not conclusively con-
firm these results.
Acifluorfen Binding—AF is a bicy-
clic non-planar molecule proposed
to mimic half of the protoporphy-
rinogen tetrapyrrole macrocycle.
Previous detailed structural com-
parison ofAF and protoporphyrino-
gen suggested that both the bond
and the torsion angles of AF at the ether oxygen match closely
with the angles at the methylene bridges between the rings of
the protoporphyrinogen macrocycle (38). In the mxPPOXAF
complex, AF is observed deep in the substrate binding pocket. It
makes no direct hydrogen bondswith the enzyme but is accom-
modated by the shape of the hydrophobic pocket and makes
three key interactions (Fig. 2B). The nitro group is held in the
active site by the positively chargedArg-95 (distance 3.4Å), and
FIGURE 1. A, the structure of mxPPOX showing FAD (yellow) and AF (green) bound and the three pseudo-
domains. Thepseudo-domains and somehelices (H) and strands (S) are labeled.B, overlayofmxPPOX (blue) and
mtPPOX (gray). C, mxPPOX with the residues equivalent to those involved in VP in human PPOX displayed in
pink. D, close-up of the VP equivalent residues. E, schematic of the PPOX substrate protoporphyrinogen IX
drawnwithMDL ISIS/Draw2.5. F, surface representation rotated 90° around the x axis fromA. Themembrane-
binding domain colored according to charge, showing the bottom potential membrane-interacting surface.
Blue indicates positive charge and white/gray the hydrophobic surfaces. The FAD and substrate-binding
domains are in brown and forest green, respectively. AF (light blue) and FAD (yellow) can be partially seen
through the hydrophobic channel.
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the carboxylate group makes water-mediated interaction with
the carbonyl oxygen of Val-164; the water occupying the posi-
tionwhere themethyl groupofmethyl-AFmight be expected to
fit. There is also an aromatic-aromatic interaction (39) between
Phe-329 and the 2-nitrobenzoic acid moiety. The non-polar
nature of the binding highlights the importance of the shape of
the inhibitor to fit this pocket, in what is presumed to be a fairly
rigid active site. In the absence of hydrogen bond formation on
inhibitor binding, the higher affinity of methyl-AF for many
PPOXs (9) may therefore be because of the gain in entropy
following the displacement of more water molecules by the
larger inhibitor.
AF, however, does not perfectly mimic the flat substrate, and
comparison of the modeled protoporphyrinogen with AF
reveals differences in theirmodes of binding. Protoporphyrino-
gen is a tetrapyrrolemacrocyclewith each of the pyrroles joined
by a methylene bridge. By contrast,
AF is based on two benzene rings
joined by an ether linkage and there-
fore is both wider than the individ-
ual pyrrole rings and longer than the
edge of the tetrapyrrole. The 2-ni-
trobenzoic acid moiety lies flat in
the pocket and is held snugly against
17, sandwiched between Arg-95,
Leu-332, and Phe-329 (Fig. 2B). The
2-chloro-4-trifluoromethylphenoxy
moiety is situated in a much wider
pocket between Met-365 and Gly-
167 and tilts at an angle of 45° rela-
tive to the plane. The extra width of
the AF 2-chloro-4-trifluoromethyl-
phenoxy moiety cannot be accom-
modated in the plane of the tetra-
pyrrole macrocycle because of the
projection of the carbonyl oxygen
of Gly-167 from the cavity floor
and is therefore channeled between
the carbonyl oxygen of Gly-167
and the cavity wall (Ile-311, Ile-412,
and Ala-170). The trifluoromethyl
group itself is sandwiched between
the isoalloxazine ring of the FAD
molecule andAla-170, and the chlo-
rine atom projects into a large
pocket in the cavity.
AF is a widely used herbicide that
inhibits many PPOX enzymes,
including ones from several bacte-
ria, plants, and humans, despite the
low sequence identity among these
enzymes. This structure reveals that
there are two side chain interac-
tions with mxPPOX, Arg-95 and
Phe-329, but that the binding also
relies on the shape of the pocket and
an additional water-mediated inter-
action with the main chain oxygen
atom. Interestingly, the PPOX from B. subtilis has been shown
to be resistant to AF inhibition (17, 18) and hence PPOX from
B. subtilis was modeled, based on the mtPPOX structure (Pro-
teinData Bank code 1SEZ, chain B) using the ESyPred3D server
(40). Although the sequence identity is low (24%), the model
mostly conserves the secondary structure. Analysis of the active
site shows that it is still of similar shape to that of mxPPOX and
mtPPOX, with no large residues protruding into it as might be
expected. One difference, though, is the increase of space in the
cavitywhere the 2-nitrobenzoic acidmoiety ofAFpacks against
the cavity wall. In mxPPOX, this wall is comprised of two bulky
residues, Arg-95 and Phe-329 that are conserved in human,
tobacco, and other eukaryotic species and make specific inter-
actions with the AF. In B. subtilis and other bacillus and bacte-
rial species, however, these residues are replaced with serine
and threonine, respectively. These residues cannot provide the
FIGURE 2. The surface of the active site with the FAD-binding domain removed for clarity (with the
exception of Ile-311), as a stereo diagram. Key residues defining the pocket are shown in stick representa-
tion and labeled. The FAD is shown in yellow andwater as red spheres. The surface is colored according to atom
colorwith red for oxygen,blue for nitrogen,white/gray for carbon, andorange for sulfur. Somehydrogenbonds
are displayed as dashed yellow lines. A, Tween 20 in green is shown in the active site with a modeled (with
minimization) protoporphyrinogen substrate on top in pink. B, the AF inhibitor is shown in light bluewith the
initial difference density (Fo  Fc at 2 in yellow) for the AF shown to extend over most of the inhibitors.
C, extendedversionofAdemonstrating the interactionsofAsn-63. Part of theFAD-bindingdomain isdisplayed
schematically (gray).
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equivalent electrostatic and aromatic interactions and are also
less bulky. Furthermore, Leu-332, at the base of the pocket,
which is also conserved in several eukaryotic species, is replaced
by a valine in B. subtilis. It is possible that the change in the
shape of this end of the pocketmakes itmore spacious, prevent-
ing the snug fit that AF has inmxPPOX and contributing to the
lower affinity for the B. subtilis enzyme. This extra space in the
active site may also allow the binding of a wider range of sub-
strates (e.g. coporphyrinogen), known for this form of the
enzyme (17, 18). The substitution of Arg-95 to serine could also
be assumed to be detrimental to substrate binding. However, a
lysine that was observed on a neighboring loop may provide an
alternative positive charge for positioning the substrate,
although unable to hold the much smaller AF in the active site.
However, there is no equivalent loop in eithermxPPOXormtP-
POX for comparison, consequently the corresponding position
of the lysine is not certain.
Membrane Interaction—Only a few monotopic membrane
proteins structures have been solved to date. Although there is
no overall homology, there are a few similarities in their mem-
brane anchoring motifs. These motifs contain a hydrophobic
patch that is thought to be buried in themembrane, often com-
prising of horizontal amphipathic helices, surrounded by an
area of positive charge (41–44). Inspection of the surface and
charge distribution of the monomeric mxPPOX (Fig. 1F) sug-
gests a probable membrane interaction/orientation, based on
comparison with these structures. The hydrophobic crystal
packing interface between the membrane-binding domains,
namely helices 4, 5, and 10, has several features suggestive of a
membrane anchor. Firstly, the surface comprises a slightly pro-
truding hydrophobic center, including a well conserved hydro-
phobic sequence (residues 195–200), surrounded by a half-ring
of positive charge (Fig. 1F). If positioned in a membrane, this
arrangement would allow the PPOX to bury the hydrophobic
center in the membrane, although stabilizing its orientation
through interactions between the ring of positive charge and
the charged lipid head groups. Secondly, the only contact of the
hydrophobic center in the crystal packing interface is via van
der Waals interactions between the central hydrophobic resi-
dues (Fig. 3B). A Tween 20 molecule was modeled circling the
protruding hydrophobic patch on the monomer, and glycerol
and water molecules were modeled near the charged half-ring.
Tween 20 and glycerol, both included in the crystallization mix
may, in part, imitate the membrane. Thirdly, the hydrophobic
center of this surface forms the opening to a hydrophobic chan-
nel that leads to the active site as could be viewed by the relative
position of the AF molecule in its binding site (Fig. 1F). If pro-
toporphyrin is channeled through the membrane, as has been
suggested (14), it could pass through this channel because it
seems to be a suitable size for it. These factors suggest that this
surface interacts with themembrane, and further elucidation is
necessary.
FIGURE 3. Illustration of the crystal packing in P4212; the FAD-binding
pseudo-domain is in brown, the substrate-binding pseudo-domain in
forest green, and themembrane-bindingpseudo-domain inmarineblue.
A, two-fold symmetry of the asymmetric unit. B, asymmetric unit with the
membrane-binding pseudo-domain represented as a charged surface (posi-
tive charge in blue, negative charge in red, and hydrophobic areas in gray),
showing the small area of interaction at the two-fold axis.C, two-fold rotation
of the asymmetric unit in the crystal. D, four-fold rotation axis.
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Dimerization—mxPPOX is a membrane-associated enzyme
that requires the presence of detergent for solubilization and
purification. In this form, it is also exclusively a homodimer, as
determined by gel filtration (15) and confirmed in our labora-
tory (data not shown). We would expect the dimer to show
two-fold symmetry, but analysis of the crystal packing inter-
faces with PISA server (45) suggests that those interfaces that
show two-fold symmetry, including the asymmetric unit, have
surface interface areas equal to or less than 226 Å2 (450 Å2
combined buried surface area), which is not suggestive of a tight
dimer (46). Furthermore, none of these two-fold symmetrical
dimers would allow the membrane binding regions of each
monomer in the dimer to be co-planar, as is reported for other
monotopic proteins (42–44) (Fig. 3). These data therefore sug-
gest that although mxPPOXmay form dimers in solution or in
the plasma membrane, these interactions are not reflected in
our structure.
The lack of a dimeric mxPPOX in the crystal structure does
not rule out its existence in the membrane. Despite the deter-
gent available in the purification buffer, this may not fully
mimic the membrane. In the case of mouse PPOX, the Km for
protoporphyrinogen in phospholipid vesicles was three-fold
less than that for the detergent-solubilized enzyme, suggesting
that some structural change or stabilization occurs in themem-
brane (47). It is possible that the greater need to bury the “mem-
brane-interacting interface” in the crystal causes the dimer to
rearrange. It was noted by Wendt et al. (42) that squalene-
hopene cyclase and prostaglandin-H2 synthase form crystals
such that the membrane-interacting interfaces encircle the
crystallographic symmetry axes, presumably reducing their sol-
vent exposure. This arrangementwas also seen in our structure,
with the membrane binding regions clustered around the four-
fold symmetry axis (Fig. 3D). However, squalene-hopene
cyclase and prostaglandin-H2 synthase form large dimeric
interfaces as well as the hydrophobic clustering in our struc-
ture; only the hydrophobic clustering was observed.
Comparisons with mtPPOX—The sequence identity among
PPOX enzymes of different species is relatively low, with the
most similar region identified as the first 60 residues (48) com-
prising the dinucleotide bindingmotif (49). Thismotif, situated
in the FAD-binding pseudo-domain, contributes toward the
binding of the phosphate, ribose, and adenine moieties of the
FAD. However, despite the low sequence identity between
mxPPOX and mtPPOX (27%), the overall fold is completely
conserved (r.m.s.d. of 1.9 Å for 435 C atoms as calculated by
the Dali server) (36). The noticeable difference, when the two
structures are superimposed, is the extra length of a couple of
loops in the FAD-binding domain, although the FAD is simi-
larly positioned in both molecules (Fig. 1B). Additionally, the
higher resolution of mxPPOX allowed themodeling of the loop
between helices 5 and 6 that was missing in the mtPPOX struc-
ture and several further water molecules in the FAD pocket.
The water observed in mtPPOX, coordinated between the cen-
tral phosphate and the nearby protein backbone, is conserved
in the mxPPOX structures, both with and without AF. Addi-
tional water was observed in the native mxPPOX at 2.7 Å,
bound between theN-5 atom of FAD andAsn-63 asmentioned
previously. Four other water molecules were observed in the
mxPPOXAF complex at 2.3 Å, forming water-mediated con-
tacts between the central phosphates of the FAD and the pro-
tein backbone.
Of significant interest are the apparent differences in the
membrane binding regions. In the case of mtPPOX it has been
proposed that it interacts with themembrane in the dimer con-
formation observed in the crystal form, whereas mxPPOX does
not form a physiologically relevant dimer in the current crystal
form. Also, although inspection of the monomeric mxPPOX
suggests a probable membrane-interacting surface, this is not
identical to that proposed for mtPPOX. Therefore, we assessed
whether mxPPOX may form a similar dimer to the one sug-
gested for mtPPOX by superimposing the two monomers of
mxPPOX on the mtPPOX dimer. Although our structure can
loosely fit this model, the resulting dimer buries part of the
proposed membrane-interacting interface including much of
the hydrophobic surface and several of the positively charged
half-ring residues. The rest of the positively charged residues
from both monomers protrude downwards toward the mem-
brane from twoprotruding helices, blocking the exposure of the
hydrophobic patch and suggesting that these helices would
more likely sit on the surface of the membrane rather than be
embedded in it. Furthermore, there seems to be no opportuni-
ties for the buried positive charges to be satisfied at the dimer
interface and fewpossibilities for specific inter-molecular inter-
actions. Based on the analysis of the charges, surface area sizes,
and potential specific interactions at these interfaces, we would
speculate that mxPPOX is not likely to form the dimer pro-
posed for mtPPOX.
We also examined whether mtPPOX has similar features to
those described for our proposed membrane-binding interface
surface. mtPPOX has a differently shaped hydrophobic patch
that protrudes slightly further from the surrounding positive
and negative charged residues. Part of the protrusion in
mtPPOX is involved in the largest dimer interface in the
mtPPOX crystal packing (not the proposed physiological
dimer), and part forms the proposed dimer interface, leading to
the conclusion that just the former of these is the membrane
contacting face. The contribution of the membrane binding
region to the crystal packing is consistentwith that observed for
mxPPOX, but the inclusion of part of it in the dimer interface
suggests that the proposed dimer could also be an artifact of
crystal packing. However, it has been reported previously that
different PPOX enzymes exist in either monomeric or dimeric
forms (50), either in solution or in the membrane, so it is also
quite possible that different PPOXs may interact differently
with the membrane or form different types of dimers. The
dimer proposed for mtPPOX seems plausible, even if it has a
small size. Also, a portion of the loop following helix 10 at the
membrane binding surface is missing in both structures, leav-
ing uncertainty as to how or whether this region may be
involved in dimerization ormembrane interaction. It is possible
that this loop becomes ordered onmembrane binding and facil-
itates dimerization in a manner that is unclear in its absence.
Finally, if mxPPOX is burying its membrane binding regions in
the crystal packing at the expense of dimerization, it poses the
questionwhether the observed dimeric state in solution is actu-
ally because of dimerization through the membrane binding
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surfaces of the monomers rather than a representation of the
membrane-associated conformation. Interestingly, it has also
been suggested that the squalene-hopene cyclase dimer is tran-
sient because of the polar nature of the dimer interface
observed in the crystal, and that the dimer may require stabili-
zation in the membrane (42). Further experiments based on
these results will be needed to test these hypotheses.
Variegate PorphyriaMutations—Of great interest within the
South African context of VP is Asn-63 (equivalent of Arg-59 in
human PPOX), which we have discussed above. However, in
general, the large sequence diversity betweenmxPPOX and the
human enzyme, combined with the nature of activity informa-
tion for various mutants, makes it hard to assess structure-
function relationships formany of themutations. Nevertheless,
there are four South African VP-associated mutations, which
can be rationalized, to some extent, in terms of our structure.
One is the R168C mutation, where the equivalent residue in
mxPPOX (Thr-166) is positioned relatively close to AF and
within 7 Å of the modeled protoporphyrinogen substrate (Fig.
1,C andD).On the other hand, asThr-166 is closer in size to the
mutant cysteine, it may be presumptuous to predict what effect
this mutation has from this structure. The second is V290M.
The mxPPOX equivalent of Val-290 and Ala-287 is positioned
some 5 Å away from the adenine terminus of the FAD cofactor.
It is possible that the bulky methionine interferes with FAD
binding or is important for the integrity of the channel. The
third and fourth mutations (L15F and H20P) both lie at the N
terminus. Leu-15 is part of a sequence that is conserved across
many species and other FAD binding proteins, constituting the
dinucleotide binding motif (49) and is itself a conserved hydro-
phobic residue (Ala, Val, Ile, or Leu). In mxPPOX, these resi-
dues are Leu-22 and His-27, respectively, and are situated in a
helix adjacent to the FAD binding site. It is possible that these
mutations may disturb FAD binding through disruption of the
helix or its packing with the surrounding elements for H20P
and L15F, respectively. Additionally, the H20P mutation has
been demonstrated to abolishmitochondrial targeting in tissue
culture assays (51).
Interestingly, a fewVP patients have been described inwhich
the R59W mutation is compounded by the inheritance of a
second non-R59W mutation, resulting in a condition referred
to as homozygous VP (52–55). The interesting feature of such
mutations is their apparent “lesser” effect on PPOX functional-
ity (human R168C, Y348C, and R138P mutations are such
examples), and a double dose of a severe mutation, such as
R59W, is lethal (35). In our structure, these residues (with the
possible exception of Arg-168, see above) appear to be in non-
critical areas, supporting their classification as lesser muta-
tions. The structure-function relationship between other
reported South African mutations is less obvious, and deter-
mining of the crystal structure of the human form of PPOX
should prove more conclusive.
CONCLUSION
The structure of PPOX from M. xanthus has been deter-
mined and shows the same fold as the previously determined
structure from tobacco mitochondrial PPOX. However, the
charge distribution and the crystal packing of our structure
suggest that mxPPOXmay not dimerize or bind themembrane
in the same way as that proposed for the tobacco enzyme. The
complex with AF has enhanced our understanding of how sub-
strates and inhibitors are accommodated in the active site.
Rationalization for some VP-causing mutations in the human
enzyme, including Arg-59, can be achieved by comparison with
the mxPPOX structure.
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